These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

123 related articles for article (PubMed ID: 25998299)

  • 21. Erratum. Innovative Designs and Logistical Considerations for Expedited Clinical Development of Combination Disease-Modifying Treatments for Type 1 Diabetes. Diabetes Care 2022;45:2189-2201.
    Anderson RL; DiMeglio LA; Mander AP; Dayan CM; Linsley PS; Herold KC; Marinac M; Ahmed ST
    Diabetes Care; 2022 Dec; 45(12):3113. PubMed ID: 36219765
    [No Abstract]   [Full Text] [Related]  

  • 22. Erratum. Genetics coming of age in type 1 diabetes. Diabetes Care 2019;42:189-191.
    Cerosaletti K; Hao W; Greenbaum CJ
    Diabetes Care; 2019 May; 42(5):987. PubMed ID: 30885949
    [No Abstract]   [Full Text] [Related]  

  • 23. Erratum. Who Is Enrolling? The Path to Monitoring in Type 1 Diabetes TrialNet's Pathway to Prevention. Diabetes Care 2019;42:2228-2236.
    Sims EK; Geyer S; Johnson SB; Libman I; Jacobsen LM; Boulware D; Rafkin LE; Matheson D; Atkinson MA; Rodriguez H; Spall M; Larsson HE; Wherrett DK; Greenbaum CJ; Krischer J; DiMeglio LA;
    Diabetes Care; 2020 Apr; 43(4):934. PubMed ID: 32132004
    [No Abstract]   [Full Text] [Related]  

  • 24. Erratum to: The new biology of diabetes.
    Pajvani UB; Accili D
    Diabetologia; 2015 Nov; 58(11):2683. PubMed ID: 26376798
    [No Abstract]   [Full Text] [Related]  

  • 25. The role of empagliflozin in the management of type 2 diabetes by patient profile.
    Hedrington MS; Davis SN
    Ther Clin Risk Manag; 2015; 11():739-49. PubMed ID: 25999725
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Management of patients with type 2 diabetes and mild/moderate renal impairment: profile of linagliptin.
    Gallwitz B
    Ther Clin Risk Manag; 2015; 11():799-805. PubMed ID: 25999728
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Impact of empagliflozin added on to basal insulin in type 2 diabetes inadequately controlled on basal insulin: a 78-week randomized, double-blind, placebo-controlled trial.
    Rosenstock J; Jelaska A; Zeller C; Kim G; Broedl UC; Woerle HJ;
    Diabetes Obes Metab; 2015 Oct; 17(10):936-48. PubMed ID: 26040302
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Empagliflozin as add-on to metformin in people with Type 2 diabetes.
    Merker L; Häring HU; Christiansen AV; Roux F; Salsali A; Kim G; Meinicke T; Woerle HJ; Broedl UC;
    Diabet Med; 2015 Dec; 32(12):1555-67. PubMed ID: 26031566
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Effect of Sitagliptin on Cardiovascular Outcomes in Type 2 Diabetes.
    Green JB; Bethel MA; Armstrong PW; Buse JB; Engel SS; Garg J; Josse R; Kaufman KD; Koglin J; Korn S; Lachin JM; McGuire DK; Pencina MJ; Standl E; Stein PP; Suryawanshi S; Van de Werf F; Peterson ED; Holman RR;
    N Engl J Med; 2015 Jul; 373(3):232-42. PubMed ID: 26052984
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Dapagliflozin lowers blood pressure in hypertensive and non-hypertensive patients with type 2 diabetes.
    Sjöström CD; Johansson P; Ptaszynska A; List J; Johnsson E
    Diab Vasc Dis Res; 2015 Sep; 12(5):352-8. PubMed ID: 26008804
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Empagliflozin/linagliptin single-tablet combination: first-in-class treatment option.
    Woo V
    Int J Clin Pract; 2015 Dec; 69(12):1427-37. PubMed ID: 26303997
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Empagliflozin (Jardiance): A Novel SGLT2 Inhibitor for the Treatment of Type-2 Diabetes.
    Ndefo UA; Anidiobi NO; Basheer E; Eaton AT
    P T; 2015 Jun; 40(6):364-8. PubMed ID: 26045645
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Efficacy and Safety of Canagliflozin Used in Conjunction with Sulfonylurea in Patients with Type 2 Diabetes Mellitus: A Randomized, Controlled Trial.
    Fulcher G; Matthews DR; Perkovic V; de Zeeuw D; Mahaffey KW; Weiss R; Rosenstock J; Capuano G; Desai M; Shaw W; Vercruysse F; Meininger G; Neal B
    Diabetes Ther; 2015 Sep; 6(3):289-302. PubMed ID: 26081793
    [TBL] [Abstract][Full Text] [Related]  

  • 34. A comprehensive review of the pharmacodynamics of the SGLT2 inhibitor empagliflozin in animals and humans.
    Michel MC; Mayoux E; Vallon V
    Naunyn Schmiedebergs Arch Pharmacol; 2015 Aug; 388(8):801-16. PubMed ID: 26108304
    [TBL] [Abstract][Full Text] [Related]  

  • 35. DPP-4 Inhibitor Linagliptin Attenuates Aβ-induced Cytotoxicity through Activation of AMPK in Neuronal Cells.
    Kornelius E; Lin CL; Chang HH; Li HH; Huang WN; Yang YS; Lu YL; Peng CH; Huang CN
    CNS Neurosci Ther; 2015 Jul; 21(7):549-57. PubMed ID: 26010513
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Comparative efficacy and safety of antidiabetic drug regimens added to stable and inadequate metformin and thiazolidinedione therapy in type 2 diabetes.
    Saulsberry WJ; Coleman CI; Mearns ES; Zaccaro E; Doleh Y; Sobieraj DM
    Int J Clin Pract; 2015 Nov; 69(11):1221-35. PubMed ID: 26215321
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Pharmacokinetics of Empagliflozin and Pioglitazone After Coadministration in Healthy Volunteers.
    Macha S; Mattheus M; Pinnetti S; Broedl UC; Woerle HJ
    Clin Ther; 2015 Jul; 37(7):1503-16. PubMed ID: 26051874
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Insulin stimulates SGLT2-mediated tubular glucose absorption via oxidative stress generation.
    Nakamura N; Matsui T; Ishibashi Y; Yamagishi S
    Diabetol Metab Syndr; 2015; 7():48. PubMed ID: 26023321
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Sotagliflozin, a Dual SGLT1 and SGLT2 Inhibitor, as Adjunct Therapy to Insulin in Type 1 Diabetes.
    Sands AT; Zambrowicz BP; Rosenstock J; Lapuerta P; Bode BW; Garg SK; Buse JB; Banks P; Heptulla R; Rendell M; Cefalu WT; Strumph P
    Diabetes Care; 2015 Jul; 38(7):1181-8. PubMed ID: 26049551
    [TBL] [Abstract][Full Text] [Related]  

  • 40.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.